Knowledge (XXG)

Irlen syndrome

Source 📝

112:
thought that filtering the visual information before reaching the brain through the use of either colored overlays or spectral filters (worn as glasses), could allow the brain to correctly process the visual information it received. They thought that in doing so, these colored overlays and spectral
113:
filters could eliminate symptoms associated with Irlen syndrome. Similar symptoms were separately described by Meares and Irlen, each unaware of the other's work. Irlen, who was the first to systematically define the condition, named the condition "
391: 94:
in the form of glasses or contact lenses. The method is intended to correct visual processing problems; it is claimed the resultant retiming of visual signals in the brain improves symptoms associated with Irlen syndrome.
107:
described the visual distortions some individuals reported when reading from white paper. In 1983, while working under a federal research grant at the California State University of Long Beach, American psychologist
133: 318:
consider this method to be a classic example of a commercial enterprise preying on vulnerable and desperate individuals in search of simple solutions for developmental disorders and disabilities
124:
Early studies investigating Irlen syndrome as a treatable condition have been criticized for having a biased and subjective approach to their research.
311: 347: 266: 200:
Miyasaka, Jordan Da Silva; Vieira, Raphael V. Gonzaga; Novalo-Goto, Elaine Shizue; Montagna, Erik; Wajnsztejn, Rubens (March 2019).
296:
Early Intervention for Young Children with Autism Spectrum Disorder – Evidence-Based Practices in Behavioral Health
386: 401: 396: 40: 104: 381: 272: 231: 109: 71:
which, it is proposed, can be treated by wearing colored lenses. The ideas of Irlen syndrome are
376: 307: 262: 223: 182: 145: 68: 299: 254: 213: 174: 72: 371: 114: 178: 117:
sensitivity syndrome," though in years following, some referred to it as Meares-Irlen
365: 276: 235: 91: 75:
and not supported by scientific evidence, and its treatment has been described as a
333: 76: 303: 291: 258: 218: 201: 251:
Pseudoscience in Child and Adolescent Psychotherapy: A Skeptical Field Guide
227: 142: – Specific learning disability characterized by troubles with reading 350:. The University of Newcastle, Australia. 13 November 2015. Archived from 186: 165:
Cotton M, Evans K (1990). "A review of the use of Irlen (tinted) lenses".
139: 118: 17: 136: – Includes changes in diet, supplements, biofeedback, and yoga. 52: 249:
LaBrot Z, Dufrene B (2019). "Chapter 5: Learning". In Hupp S (ed.).
202:"Irlen syndrome: systematic review and level of evidence analysis" 392:
Alternative therapies for developmental and learning disabilities
134:
Alternative therapies for developmental and learning disabilities
351: 47: 292:"Fad, Pseudoscientific, and Controversial Interventions" 290:
Travers JC, Ayers K, Simpson RL, Crutchfield S (2016).
67:) is a hypothetical medical condition of disordered 167:
Australian and New Zealand Journal of Ophthalmology
46: 39: 34: 334:"Irlen Syndrome | Science-Based Medicine" 253:. Cambridge University Press. pp. 66–79. 8: 90:The Irlen method uses colored overlays and 217: 82:The condition was proposed in the 1980s. 348:"The University of Newcastle, Australia" 294:. In Lang R, Hancock T, Singh N (eds.). 157: 79:taking advantage of vulnerable people. 31: 328: 326: 121:, Irlen syndrome, and visual stress. 7: 179:10.1111/j.1442-9071.1990.tb00625.x 25: 298:. Springer. pp. 257–293. 1: 206:Arquivos de Neuro-Psiquiatria 103:In 1980, New Zealand teacher 65:scotopic sensitivity syndrome 304:10.1007/978-3-319-30925-5_9 418: 259:10.1017/9781316798096.007 219:10.1590/0004-282X20190014 27:Proposed vision disorder 41:Pseudomedical diagnosis 387:Alternative diagnoses 354:on 12 January 2007. 313:978-3-319-30923-1 146:Semmelweis reflex 69:visual processing 58: 57: 16:(Redirected from 409: 356: 355: 344: 338: 337: 336:. 7 August 2013. 330: 321: 320: 287: 281: 280: 246: 240: 239: 221: 197: 191: 190: 162: 73:pseudoscientific 32: 21: 417: 416: 412: 411: 410: 408: 407: 406: 362: 361: 360: 359: 346: 345: 341: 332: 331: 324: 314: 289: 288: 284: 269: 248: 247: 243: 199: 198: 194: 164: 163: 159: 154: 130: 101: 88: 28: 23: 22: 15: 12: 11: 5: 415: 413: 405: 404: 399: 394: 389: 384: 379: 374: 364: 363: 358: 357: 339: 322: 312: 282: 267: 241: 212:(3): 194–207. 192: 156: 155: 153: 150: 149: 148: 143: 137: 129: 126: 100: 97: 87: 84: 61:Irlen syndrome 56: 55: 50: 44: 43: 37: 36: 35:Irlen syndrome 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 414: 403: 402:Pseudoscience 400: 398: 395: 393: 390: 388: 385: 383: 380: 378: 375: 373: 370: 369: 367: 353: 349: 343: 340: 335: 329: 327: 323: 319: 315: 309: 305: 301: 297: 293: 286: 283: 278: 274: 270: 268:9781107175310 264: 260: 256: 252: 245: 242: 237: 233: 229: 225: 220: 215: 211: 207: 203: 196: 193: 188: 184: 180: 176: 173:(3): 307–12. 172: 168: 161: 158: 151: 147: 144: 141: 138: 135: 132: 131: 127: 125: 122: 120: 116: 111: 106: 98: 96: 93: 92:tinted lenses 85: 83: 80: 78: 74: 70: 66: 62: 54: 51: 49: 45: 42: 38: 33: 30: 19: 397:Health fraud 352:the original 342: 317: 295: 285: 250: 244: 209: 205: 195: 170: 166: 160: 123: 105:Olive Meares 102: 89: 86:Irlen method 81: 77:health fraud 64: 60: 59: 29: 110:Helen Irlen 366:Categories 152:References 382:Syndromes 277:240819473 236:108293945 377:Dyslexia 228:30970133 140:Dyslexia 128:See also 119:syndrome 115:scotopic 187:2261178 99:History 18:Asfedia 372:Vision 310:  275:  265:  234:  226:  185:  53:Nocebo 273:S2CID 232:S2CID 48:Risks 308:ISBN 263:ISBN 224:PMID 183:PMID 63:(or 300:doi 255:doi 214:doi 175:doi 368:: 325:^ 316:. 306:. 271:. 261:. 230:. 222:. 210:77 208:. 204:. 181:. 171:18 169:. 302:: 279:. 257:: 238:. 216:: 189:. 177:: 20:)

Index

Asfedia
Pseudomedical diagnosis
Risks
Nocebo
visual processing
pseudoscientific
health fraud
tinted lenses
Olive Meares
Helen Irlen
scotopic
syndrome
Alternative therapies for developmental and learning disabilities
Dyslexia
Semmelweis reflex
doi
10.1111/j.1442-9071.1990.tb00625.x
PMID
2261178
"Irlen syndrome: systematic review and level of evidence analysis"
doi
10.1590/0004-282X20190014
PMID
30970133
S2CID
108293945
doi
10.1017/9781316798096.007
ISBN
9781107175310

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.